Company Introduction
S&P PHARMACEUTICAL CO., LTD whose old name is Qinghai S&P Pharmaceutical Co., Ltd is a joint stock company established on 17, May.1994 by collection approved by the No.21 File of the year 1994 issued by Qinghai Province Economy System Reform Office and issued the stock on 11, Aug.1994 approved by the No.ZJF 30 File of the year of 1994, issued by China Securities Regulatory Commission and began to exchange in Shanghai Exchange Stock on 6, February.1955 whose stock code is 600869.S&P Pharmaceutical Co., Ltd is registered in Qinghai Province Administrator for Industry & Commerce whose registered address is No.58 Delingha Road East of Xining City Qinghai Province and legal representative is Jiang Xipei. The register No. is 630000100009098. The compamy subsidiary are Far East Cable Co., Ltd.,Jiangsu New Far East Cable Co., Ltd.,Far East Composite Technology Co., Ltd., Qinghai Pharmaceutical Co., Ltd., Shanghai Bolai Enterprise Development Co., Ltd..
The foundation of our company is Qinghai Chinese Medical Factory established in 1969. After hard work and study for many years now it has grown to be the biggest base producing Chinese and Tibet Medicine. Our company has three subsidiary company including Qinghai Province Pharmaceutical Co., Ltd, S&P Pharmaceutical Chain Co., Ltd and Shanghai Baolai Enterprise Development Co., Ltd.Our company has more than 100 kinds of products including drug for cardiovascular and cerebrovascular and drug for breath system and health care foodstuff. The main products including S&P Jianpian for hepatitis and S&P Xinnaoxin capsule and S&P Lifei and S&P Chongcao Shenshi oral liquid and S&P Hongjingtian capsule all produced by local natural medical material in Qinghai Province.
Our company passed through the GMP(Good Manufactory Practice) certification examined by State Drug Administration in Sep.The total capital stock amounts increased from 120 million to 427.432684 million yuan.The company's main business is wire and cable and medicine, and became the leader of electric wire and cable industry, asset scale and profitability boosted, company made full use of the management ability and brand appeal in the field of wire and cable business for many years, and kept to be the leader in wire and cable industry , further improved the company's reputation and influence, regulated and improved operation and management, and enhanced the competitive ability in the industry. At the same time grasp the opportunity of Chinese medicine manufacturing development, promoted the development of company's original medical business.
|